“Elsevier, though? You can’t find a gaffe too big for them to try on. Jack up journal prices so high that even the best-endowed university in the country can’t afford them? Check. Publish fake journals that turn out to have been sponsored by pharmaceutical companies? Check. Buy up the start-ups that threaten your business model and use all the data that was freely submitted by its users for your own ends? Oh, check, check, check.” –

Leave a Reply